Cafepharma Today

January 24 2024 - Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11%
Novo Nordisk links next-gen obesity drug to 22% weight loss at Week 36, sending stock up 11%
Moderna races to create norovirus vaccines
Merck, Eisai's star-crossed Keytruda-Lenvima combo misses survival goal in GI cancer trial
Trump administration delays funding to cancer research
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Sepracor shares jump on cost cuts, profit outlook
Yahoo/AP
Thursday, January 29, 2009 - 7:57pm
tags:
earnings, Sepracor, Lunesta
Report: Growth in Calif.'s biomed industry stalls
Yahoo/AP
Thursday, January 29, 2009 - 7:55pm
tags:
biotech, California
FDA Panel to Consider Fate of Pain Pills Darvon, Darvocet
WSJ Online
Thursday, January 29, 2009 - 7:54pm
tags:
Darvocet, painkillers, Darvon
Sequenom Still Very Good, Just No Longer Perfect
TheStreet.com
Thursday, January 29, 2009 - 10:54am
tags:
Sequenom, genetic testing
[video]Gilead: Buying This Stock on Weakness
Yahoo/TheStreet.com
Thursday, January 29, 2009 - 10:54am
tags:
biotech, Gilead Sciences
GlaxoSmithKline takes $400 million legal charge
Yahoo/AP
Thursday, January 29, 2009 - 10:53am
tags:
GSK
BMS Tops List of Patent Approvals
PharmExec
Thursday, January 29, 2009 - 10:17am
tags:
Bristol-Myers Squibb, patents
Wyeth deal fails to create spark
Guardian,UK
Thursday, January 29, 2009 - 10:14am
tags:
Wyeth, Pfizer, buyouts
Pozen: Finally Some Good News
Yahoo/Zacks.com
Thursday, January 29, 2009 - 10:01am
tags:
Pozen, AstraZeneca, Merck, Pfizer, ulcers, PN-400
CV Therapeutics will review Astellas offer again
Forbes
Thursday, January 29, 2009 - 9:55am
tags:
CV Therapeutics, Astellas, buyouts
Genentech's stock hop
Fierce Pharma
Thursday, January 29, 2009 - 9:54am
tags:
Genentech, Roche, buyouts
Updated Clinical Trial and FDA Calendars
Seeking Alpha
Thursday, January 29, 2009 - 9:13am
tags:
FDA, drug trials, Watson Pharmaceuticals, Savient, ARCA biopharma, Theravance
Celgene Tops Estimates; Sales Surge 50%
TheStreet.com
Thursday, January 29, 2009 - 9:11am
tags:
Celgene, earnings
Job Reaper Hits AstraZeneca and Sepracor
WSJ Online
Thursday, January 29, 2009 - 9:11am
tags:
layoffs, AstraZeneca, Sepracor
Savient shares rise after FDA schedules March meeting to review gout drug
Yahoo/AP
Thursday, January 29, 2009 - 8:24am
tags:
Savient, gout, FDA, Puricase
Generic Toprol XL Scarce, After Problems at Novartis and KV
WSJ Online
Thursday, January 29, 2009 - 8:22am
tags:
generics, Toprol XL, KV Pharmaceutical, Novartis, Sandoz, recalls
Lilly Reports $3.63 Billion Loss After ImClone Deal
Bloomberg
Thursday, January 29, 2009 - 7:26am
tags:
Eli Lilly, earnings, ImClone
The Changing Business of Pharma in the Year of the Ox
Seeking Alpha
Thursday, January 29, 2009 - 7:06am
tags:
Wyeth, Pfizer, pharma industry
AstraZeneca to cut another 6,000 jobs by 2013 despite 9 percent 2008 net profit rise
Yahoo/AP
Thursday, January 29, 2009 - 7:05am
tags:
AstraZeneca, earnings, layoffs
Sepracor 4Q swings to 4Q profit on cost cuts
Yahoo/AP
Thursday, January 29, 2009 - 6:21am
tags:
Sepracor, earnings

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline
Informa Connect's Patient Assistance & Access Programs (PAP)
Drug Channels
2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline
Versatile Chaperones
In the Pipeline

Latest Jobs

Onsite Endoscopic Specialist - Operating Room Support
Santa Monica, California
KARL STORZ Endoscopy - America
Area Manager, Immunology Rochester, NY Territory
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Tarrytown, NY
Tarrytown, New York
Lundbeck
Area Manager Specialty, West- Central
Fields, Oregon, 97710
CSL Behring
Area Sale Manager, Immunology Tampa North
Fields, Oregon, 97710
CSL Behring
Sales Representative
Boise, Idaho, 83708
Bartlett Roofing
Capital Project Manager
Carteret, New Jersey, United States
The Spear Group
Area Manager Specialty, West
Fields, Oregon, 97710
CSL Behring
Psychiatry Account Manager - Midland, TX
Midland, Texas, 79701
Lundbeck
Home Health and Medical Sales
The Woodlands, Texas, 77381
Comfort Keepers of Dallas TX
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information